TY  - GEN
AU  - Smith,Sheila Weiss
TI  - Sidelining safety--the FDA's inadequate response to the IOM
SN  - 1533-4406
PY  - 2007///0910
KW  - Drug Approval
KW  - legislation & jurisprudence
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Government Regulation
KW  - Models, Organizational
KW  - National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
KW  - Organizational Innovation
KW  - Product Surveillance, Postmarketing
KW  - United States
KW  - United States Food and Drug Administration
KW  - organization & administration
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1056/NEJMp078157
ER  -